In excess of 7 million people worldwide die of coronary heart
disease each year. Only one-third of these heart attack victims
recover completely. The remainder suffer the consequences of
myocardial infarction and its ill fated remodeling process,
resulting in chronic congestive heart failure. This malady alone is
the leading cause of hospital admissions in the United States.
New breakthroughs in stem cell therapy and tissue engineering
have promised to reverse this dismal outcome by cardiovascular
repair. World authorities, including scientists and regulatory
authorities, have joined in a collaborative effort to present for
the reader the first collective review of stem cell therapy for the
treatment of cardiovascular disease. These contributions in basic
science, pre-clinical and clinical experience guided by the
regulatory pathways, assure a rapid course of translational
research and clinical trials.
The contents of this publication will become a prerequisite for
those preparing to meet the challenges of this exciting and
potentially rewarding field of stem cell research.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!